πŸ‡ΊπŸ‡Έ FDA
Patent

US 9408829

Inhibitors of CD40-TRAF6 interaction

granted A61KA61K31/137A61K31/341

Quick answer

US patent 9408829 (Inhibitors of CD40-TRAF6 interaction) held by Ludwig-Maximilians-Universitat Munchen expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Ludwig-Maximilians-Universitat Munchen
Grant date
Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
1
CPC classes
A61K, A61K31/137, A61K31/341, A61K31/381, A61P